Albuminuria may be a biomarker of generalized (i.e., microvascular and macrovascular) endothelial dysfunction. According to this concept, endothelial dysfunction of the renal microcirculation causes albuminuria by increasing glomerular capillary wall permeability and intraglomerular pressure, the latter eventually leading to glomerular capillary dropout (rarefaction) and further increases in intraglomerular pressure. However, direct evidence for an association between capillary rarefaction and albuminuria is lacking. Therefore, we examined the cross-sectional association between the recruitment of capillaries after arterial occlusion (capillary density during postocclusive peak reactive hyperemia) and during venous occlusion (venous congestion), as assessed with skin capillaroscopy, and albuminuria in 741 participants of the Maastricht Study, including 211 participants with type 2 diabetes. Overall, 57 participants had albuminuria, which was defined as a urinary albumin excretion $30 mg/24 h. After adjustment for potential confounders, participants in the lowest tertile of skin capillary recruitment during postocclusive peak reactive hyperemia had an odds ratio for albuminuria of 2.27 (95% confidence interval, 1.07 to 4.80) compared with those in the highest tertile. Similarly, a comparison between the lowest and the highest tertiles of capillary recruitment during venous congestion yielded an odds ratio of 2.89 (95% confidence interval, 1.27 to 6.61) for participants in the lowest tertile. In conclusion, lower capillary density of the skin microcirculation independently associated with albuminuria, providing direct support for a role of capillary rarefaction in the pathogenesis of albuminuria.
(i.e., the macrocirculation) leads to atherothrombotic cardiovascular disease. 2, 3 Indeed, studies using flow-mediated dilation of the brachial, [5] [6] [7] [8] [9] femoral, 10 and left anterior descending coronary artery 11 have provided strong direct evidence for the presence of endothelial dysfunction in the macrocirculation of individuals with albuminuria.
In contrast, evidence for endothelial dysfunction in the microcirculation of individuals with albuminuria is primarily indirect, because it derives from studies using plasma biomarkers, [12] [13] [14] [15] [16] [17] the transcapillary escape rate of albumin, [18] [19] [20] [21] strain-gauge plethysmography after forearm ischemia, 22 and laser Doppler flowmetry after either iontophoresis of acetylcholine and sodium nitroprusside 23 or arterial occlusion. 24 In addition, evidence for an association between capillary rarefaction and albuminuria is confined to a relatively small study, which showed the frequent co-occurrence of both in individuals with hypertension. 25 In view of these considerations, we examined in a population-based cohort study the hypothesis that capillary rarefaction is associated with albuminuria. To do this, we used skin capillaroscopy, because capillary rarefaction in the kidney cannot be studied noninvasively in humans. Skin capillaroscopy is a noninvasive technique that allows direct visualization of capillary density in skin by measuring the recruitment of capillaries in response to arterial and venous occlusion, which are thought to be measures of functional and structural capillary density. 26 
RESULTS

Characteristics of the Study Population
For this study on the basis of the first dataset of the Maastricht Study (n=866), four participants with type 1 diabetes were excluded. In the remaining 862 participants, qualitatively satisfactory data on skin capillaroscopy were available in 818 participants. In another 12 participants, the 24-hour urine collections either were collected erroneously (,20 or .28 hours) or were not handed in at all. Of the remaining 806 participants, we additionally excluded participants with missing data on waist circumference (n=3), smoking behavior (n=14), alcohol consumption (n=17), total cholesterol-to-HDL cholesterol ratio (n=8), triglycerides (n=7), eGFR (n=15), office BP (n=2), and/or prior cardiovascular disease status (n=32). These missing data were not mutually exclusive. The study population, therefore, consisted of 741 participants. Table 1 shows the clinical characteristics of the study population stratified according to tertiles of the percentage recruitment during postocclusive peak reactive hyperemia. Tertile 1 indicates the tertile with the highest level of capillary recruitment.
In general, participants with the lowest recruitment were more often men, were less educated, suffered more often from hypertension and type 2 diabetes, and were more often treated with lipid-modifying or antihypertensive medication. Clinical characteristics according to tertiles of the percentage recruitment during venous congestion are shown in Supplemental  Table 1 .
Recruitment of Skin Capillaries and the Presence of Albuminuria
Overall, participants with the lowest recruitment more often had albuminuria (Figure 1) .
After adjustment for potential confounders and compared with participants with the highest percentage recruitment during postocclusive peak reactive hyperemia (reference category), the odds ratio (OR) and 95% confidence interval (95% CI) for albuminuria for participants in the lowest tertile were OR, 2.27 and 95% CI, 1.07 to 4.80 (Table 2 , model 3a). After adjustment for potential confounders and compared with participants with the highest percentage recruitment during venous congestion (reference category), the OR (95% CI) for albuminuria for participants in the lowest tertile was 2.89 (95% CI, 1.27 to 6.61) ( Table 2 , model 3a).
When we replaced office systolic BP with 24-hour average ambulatory systolic BP (n=665), the OR (95% CI) for albuminuria became 2.19 (95% CI, 0.96 to 5.00) for those with the lowest percentage recruitment during postocclusive peak reactive hyperemia (Table 2 , model 3b) and 2.68 (95% CI, 1.10 to 6.52) for those with the lowest percentage recruitment during venous congestion (Table 2 , model 3b).
When we replaced the percentage change in capillary density with the absolute numbers of capillaries during postocclusive peak reactive hyperemia as well as during venous congestion, the results were similar (Table 3) .
When the variables of models 3a and 3b were added separately to a model adjusted for age and sex, adjustment for type 2 diabetes led to the largest reduction of the OR when the percentage recruitment was the determinant. When the absolute number of capillaries was the determinant, adding additional variables after initial adjustment for age and sex did not materially alter our results (data not shown).
Analyses with interaction terms suggested that the associations between the percentage recruitment during postocclusive peak reactive hyperemia as well as venous congestion and albuminuria were only present in individuals without type 2 diabetes (P value of the interaction term [P interaction ] ,0.10) (Supplemental Table 2 ), whereas no such interaction was observed for the absolute number of capillaries under both conditions (P interaction .0.10) (Supplemental Table 3 ).
Additional Analyses
First, recruitment of capillaries may be expressed as either the absolute or percentage change in capillary density (Concise Methods). When we replaced the percentage change with absolute change in capillary density, results were not materially altered for either postocclusive peak reactive hyperemia or venous congestion (data not shown). Second, mutual adjustment for the percentage recruitment during venous congestion or the percentage recruitment during postocclusive peak reactive hyperemia suggested multicollinearity (i.e., a strong increase in the standard error of the regression coefficient of the central determinant; data not shown). Third, results were not materially altered when we excluded participants with an albumin excretion .300 mg/24 h; when we replaced office systolic BP with office diastolic BP, office pulse pressure, office mean arterial pressure, presence of hypertension, 24-hour average ambulatory diastolic BP, 24-hour average ambulatory pulse pressure, or 24-hour average ambulatory mean arterial pressure; when we replaced the use of antihypertensive medication with the use of a renin-angiotensin system inhibitor, the use of a diuretic, or their combined use; when we replaced waist circumference with waist-to-hip ratio or body mass index; when we replaced the total cholesterol-to-HDL cholesterol ratio with LDL and HDL; or when we additionally adjusted for hemoglobin A1c (HbA1c) or an inflammation Z score (n=738). Fourth, analyses in the subpopulation with two urine collections (n=666) and the subset of 24-hour urine collections with measured 24-hour urine creatinine excretion within 30% of expected values (n=642) did not indicate nondifferential misclassification caused by biologic variability and inaccurate collection, respectively (data not shown). Fifth, analyses on the basis of quintiles and deciles of the respective capillaroscopy measures were also consistent with a threshold level (Supplemental Tables 4-6 ). However, these analyses were hampered by a loss of power. Sixth, we defined albuminuria as an albumin excretion $15 mg/24 h, in agreement with the fact that an association with (cardiovascular disease) mortality already exists at levels of urinary albumin excretion ,30 mg/24 h 1 and to explore whether misclassification of albuminuria status occurred with the clinical cutoff value. With this definition, the associations for the entire study population became somewhat weaker (Supplemental Table  7 ), and there was no statistical interaction with type 2 diabetes (P interaction .0.10). Seventh, multivariable linear regression analyses showed no associations between tertiles of the respective capillaroscopy measures and (inverse square root-transformed) continuous urinary albumin excretion (data not shown).
DISCUSSION
The main finding of this population-based study is that lower capillary density was associated with the presence of albuminuria, regardless of whether type 2 diabetes was present. This association was independent of cardiovascular disease risk factors, including 24-hour average ambulatory BP and biomarkers of low-grade inflammation. To the best of our knowledge, this is the first population-based study that provides direct support for a role of capillary rarefaction in the pathogenesis of albuminuria. An association between capillary rarefaction and albuminuria is in agreement with the Brenner hypothesis 4 (i.e., an increase in intraglomerular pressure will lead to glomerular capillary dropout [rarefaction] and further increases in intraglomerular pressure on the one hand and greater permeation of albumin through the glomerular capillary wall on the other hand). Indeed, in individuals with type 2 diabetes, estimated intraglomerular pressure was higher in the presence of albuminuria. 27 Additionally, in individuals who underwent a large reduction in renal mass, remaining kidney mass was inversely associated with urinary albumin excretion. 28 Furthermore, in a smaller study, capillary rarefaction in the skin microcirculation and albuminuria frequently co-occurred in individuals with hypertension. 25 This study extends this knowledge, because it is the first to examine a direct measure of capillary rarefaction in a large population-based sample with adjustment for potential confounders.
A key assumption underlying this study is that skin capillary rarefaction reflects capillary rarefaction of the kidney. Although the skin microcirculation has not been compared directly with that of the kidney, several observations support the view that it is representative for the systemic microcirculation, including the kidney's. First, age-related changes in the skin microcirculation parallel those in the systemic vasculature. 29 Second, the microcirculation of the skin and kidney share associations with salt-sensitive hypertension 30 and low birth weight. [31] [32] [33] [34] Both capillary density during venous occlusion and capillary density after arterial occlusion were used as reproducible 26, 35 estimates of maximal skin capillary density. 36 In this study, we could not determine to what extent differences in capillary density were caused by structural (i.e., anatomic) or functional (i.e., nonperfusion) rarefaction. However, the occurrence of multicollinearity after mutual adjustment suggests that both measures assessed the same or at least overlapping construct(s) in this study.
Importantly, misclassification of albuminuria status because of the use of renin-angiotensin system inhibitors may explain why capillary rarefaction in individuals with type 2 diabetes was associated with albuminuria when defined as an albumin excretion $15 mg/24 h but not when defined as an albumin excretion $30 mg/24 h. Renin-angiotensin system inhibitors reduce urinary albumin excretion by lowering intraglomerular pressure, 37, 38 an effect that is enhanced by diuretics, 39 and an albumin excretion $30 mg/24 h is used as an indication for their use, particularly in individuals with type 2 diabetes. 40 Hence, individuals previously having had an albumin excretion $30 mg/24 h could be classified erroneously as having no albuminuria with this definition, thus obscuring an association with capillary rarefaction. Indeed, the frequent use of renin-angiotensin system inhibitors in individuals with type 2 diabetes and a urinary albumin excretion of 15-30 mg/24 h (64.9% versus 19.5% in individuals with a similar urinary albumin excretion but without type 2 diabetes) supports this explanation. Alternatively, the statistically significant interaction between type 2 diabetes and the percentage recruitment during postocclusive peak reactive hyperemia as well as venous congestion may be attributable to the play of chance given the low number of cases. A lack of power because of the small variation in urinary albumin excretion with only a few individuals with an albumin excretion $30 mg/24 h may explain why the results of this study suggest a threshold level for capillary density and why capillary rarefaction was not associated with continuous urinary albumin excretion. In addition, we measured urinary albumin excretion instead of the permeation of albumin through the glomerular capillary wall, and small increases in permeation may be compensated for by tubular reabsorption. 41 A strength of this study is that participants of the Maastricht Study were well characterized, allowing adjustment for an extensive series of potential confounders, including 24-hour average ambulatory BP and low-grade inflammation. In this regard, the use of office BP only could have underestimated any effect of BP on albuminuria and thereby, overestimated the association between capillary rarefaction and albuminuria. However, some of the variables in our models may also be intermediates in the association between capillary rarefaction and albuminuria, possibly leading to overadjustment bias (i.e., the associations reported are conservative). 42 For instance, capillary rarefaction may be involved in the pathogenesis of type 2 diabetes, which may subsequently lead to albuminuria via a hyperglycemia-induced increase in glomerular capillary wall permeability. 3 Similarly, higher BP may be both a cause and a consequence of capillary rarefaction. 43 From a clinical perspective, both capillary rarefaction itself and the resulting increase in intraglomerular pressure may be a target in the management of albuminuria. Indeed, reninangiotensin system inhibitors, which reduce intraglomerular pressure, 37, 38 form the mainstay of the current management of albuminuria. 40 However, current management is not specifically aimed at regenerating glomeruli. Nonetheless, in a recent study, treatment with a renin-angiotensin system inhibitor led to an increase in kidney vasculature in a rat model of progressive glomerular injury, 44 suggesting that capillary rarefaction itself could be a future therapeutic target.
This study had some limitations. First, no direct measure of capillary rarefaction of the kidney was used. However, at present, capillary rarefaction of the kidney, in contrast to capillary rarefaction of skin, cannot be studied noninvasively in humans. Second, because of the logistics of this large-scale population-based study, participants were not asked to come in fasting. However, to minimize the effects of dietary intake on the microcirculation, [45] [46] [47] participants were asked to have a standardized low-fat breakfast (or lunch) and refrain from caffeine-containing beverages and smoking. In addition, results were not materially altered after adjustment for nonadherence to the dietary and smoking restrictions. Third, the ORs represent the odds of having albuminuria (defined as an albumin excretion $30 mg/24 h) in the respective tertile of the absolute number of capillaries during postocclusive peak reactive hyperemia or venous congestion compared with the odds of having albuminuria in the reference tertile. Model 1 is the unadjusted model. Model 2 is adjusted for age, sex, and type 2 diabetes. Model 3a is model 2 adjusted for waist circumference, total cholesterol-to-HDL cholesterol ratio, triglycerides, use of lipid-modifying drugs, office systolic BP, use of antihypertensive medication, eGFR, prevalent cardiovascular disease, smoking behavior, alcohol consumption, and educational level. Model 3b is model 3a adjusted for 24-hour average ambulatory systolic BP instead of office systolic BP (n=665).
cross-sectional design does not allow us to make strong causal inferences. In addition, a longitudinal design with frequent assessment of urinary albumin excretion and medication use would have avoided misclassification of albuminuria status. Fourth, the study population primarily consisted of white individuals of European descent (99.2%), limiting generalizability to other populations.
In conclusion, lower capillary density of the skin microcirculation was independently associated with the presence of albuminuria, regardless of the presence of type 2 diabetes. Thereby, this is the first population-based study that provides direct support for a role of capillary rarefaction in the pathogenesis of albuminuria.
CONCISE METHODS
The Maastricht Study Population and Design
In this study, we used data from the Maastricht Study, an observational prospective population-based cohort study. The rationale and methodology have been described previously. 48 In brief, the study focuses on the etiology, pathophysiology, complications, and comorbidities of type 2 diabetes mellitus and is characterized by an extensive phenotyping approach. Eligible for participation were all individuals with ages between 40 and 75 years living in the southern part of The Netherlands. Participants were recruited through mass media campaigns and from the municipal registries and the regional Diabetes Patient Registry via mailings. Recruitment was stratified according to known type 2 diabetes status for reasons of efficiency. This report includes cross-sectional data from the first 866 participants who completed the baseline survey between November of 2010 and March of 2012. The examinations of each participant were performed within a time window of 3 months. The study has been approved by the institutional medical ethical committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of The Netherlands on the basis of the Health Council's opinion (Permit 131088-105234-PG) and was conducted in accordance with the Declaration of Helsinki. All participants gave written informed consent.
Skin Capillaroscopy
All participants were asked to refrain from smoking and drinking coffee or tea $3 hours before the measurements. A light meal (breakfast and/or lunch) low in fat content was allowed before the start of the measurements. Skin capillaroscopy measurements were performed in a quiet, temperature-controlled room (T=24°C) with participants in the supine position as previously described. 49 Briefly, capillaries were visualized in the dorsal skin of the distal phalanges of the third and fourth finger of the right hand by use of a digital video microscope (Capiscope; KK Technology, Honiton, United Kingdom) with a system magnification of 3100. 49 Capillaries were visualized 4.5 mm proximal to the terminal row of capillaries in the middle of the nailfold. The investigator selected a region of interest of 1-mm 2 skin area. Capillary density (mean of two fields) was measured under three conditions. First, baseline capillary density was measured. Baseline capillary density was defined as the number of continuously erythrocyte-perfused capillaries per 1 mm 2 skin and was counted for 15 seconds. Second, capillary recruitment during postocclusive peak reactive hyperemia was assessed after 4 minutes of arterial occlusion. Arterial occlusion was applied using a miniature cuff at the base of the investigated finger inflated to suprasystolic pressure (260 mmHg) for 4 minutes. Directly after release of the cuff, all (continuously and intermittently) perfused capillaries were counted for 15 seconds. Third, venous congestion was applied, with the cuff inflated to 60 mmHg for 2 minutes, and all (continuously and intermittently) perfused capillaries were counted for 15 seconds. The number of perfused capillaries was counted in the recorded digital raw data with the use of a semiautomatic procedure (CapiAna) 49 by two investigators who were blinded to participants' clinical status. The intra-and interobserver coefficients of variation for the counting procedure were 2.5% and 5.6%, respectively, as described previously. 49 For the primary analyses, we used recruitment during postocclusive peak reactive hyperemia as well as during venous congestion (expressed as the percentage change in capillary density from baseline) and the absolute number of capillaries during postocclusive peak reactive hyperemia as well as during venous congestion (expressed as capillaries per 1 mm 2 ).
Kidney Function
GFR was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation on the basis of both serum creatinine and serum cystatin C (Supplemental Material). 50 To assess urinary albumin excretion, participants were requested to collect two 24-hour urine collections (Supplemental Material). Albuminuria was defined as an albumin excretion $30 mg/24 h, 51 which is used in clinical practice to guide cardiovascular disease prevention, particularly in individuals with type 2 diabetes. 40 In an additional analysis, albuminuria was defined as an albumin excretion $15 mg/24 h (the upper level of daily albumin excretion in healthy individuals 52 ) in agreement with the fact that an association with (cardiovascular disease) mortality already exists at levels of urinary albumin excretion ,30 mg/24 h 1 and to explore whether misclassification of albuminuria status occurred with the clinical cutoff. These definitions were preferably on the basis of the average of two (available in 89.9% of the participants) 24-hour urine collections.
Participants were divided into tertiles of the percentage recruitment during postocclusive peak reactive hyperemia as well as into tertiles of the percentage recruitment during venous congestion, because the association with albuminuria seemed to be nonlinear. Participants with normal glucose tolerance, impaired fasting glucose, and impaired glucose tolerance were combined into one category (participants without type 2 diabetes) because of the small number of participants with impaired fasting glucose and impaired glucose tolerance.
Associations between tertiles of the percentage recruitment during postocclusive peak reactive hyperemia as well as during venous congestion and the presence of albuminuria were evaluated using multivariable logistic regression analyses. Similarly, associations between tertiles of the absolute number of capillaries during postocclusive peak reactive hyperemia as well as during venous congestion and the presence of albuminuria were evaluated. The tertile with the highest recruitment or the highest absolute number of capillaries (tertile 1) was used as reference category. Next, we adjusted for potential confounders as follows: model 1, unadjusted model; model 2, adjusted for age, sex, and type 2 diabetes; model 3a, model 2 adjusted for waist circumference, total cholesterol-to-HDL cholesterol ratio, triglycerides, use of lipid-modifying medication, office systolic BP, use of antihypertensive medication, eGFR, prevalent cardiovascular disease, smoking behavior, alcohol consumption, and educational level; and model 3b, model 3a with replacement of office systolic BP by 24-hour average ambulatory systolic BP.
We used interaction terms to examine whether the associations were modified by the presence or absence of type 2 diabetes. A P interaction ,0.10 in model 3a was considered to indicate a statistically significant interaction.
Adjusted percentages of participants with albuminuria per tertile of recruitment were derived from the logistic regression models (model 2) with adjustment for age, sex, and type 2 diabetes by marginal standardization 55 (calculated with Stata Statistical Software, release 11.2SE; StataCorp., College Station, TX).
Several additional analyses were performed, each starting from the models described above. First, we used the absolute change in capillary density from baseline (expressed as capillaries per 1 mm 2 ) during postocclusive peak reactive hyperemia and during venous congestion to categorize participants. Second, we excluded participants with an albumin excretion .300 mg/24 h (n=8). Third, we replaced office systolic BP with office diastolic BP, office pulse pressure, office mean arterial pressure, presence of hypertension, 24-hour average ambulatory diastolic BP, 24-hour average ambulatory pulse pressure, or 24-hour average ambulatory mean arterial pressure in model 3a, and we replaced the use of antihypertensive medication with the use of a renin-angiotensin system inhibitor, the use of a diuretic, or their combined use. Fourth, we replaced waist circumference with waistto-hip ratio or body mass index, replaced the total cholesterol-to-HDL cholesterol ratio with LDL and HDL, and additionally, adjusted for HbA1c and a Z score of the inflammation biomarkers 54 in model 3a. Fifth, we repeated the analyses in participants with two urine collections and after exclusion of 24-hour urine collections with a measured 24-hour urine creatinine excretion not within 30% of expected values 56 to explore whether biologic variation and inaccurate collection, respectively, led to nondifferential misclassification with bias toward zero. Sixth, we repeated the analyses with quintiles and deciles of the respective capillaroscopy measures as independent variables. Seventh, we repeated the analyses with albuminuria defined as an albumin excretion $15 mg/24 h. Eighth, we performed multivariable linear regression analyses to examine whether the capillaroscopy measures were associated with urinary albumin excretion on a continuous scale. Urinary albumin excretion had to be transformed by taking the inverse square root of urinary albumin excretion to fulfill the normality assumption, because it was highly positively skewed and could not be transformed adequately using common 57 transformations. 
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